Elon Musk’s Neuralink secures $280m for brain implants development
Neuralink is engaged in the development of implantable brain-computer interfaces, which are designed to enable direct communication between…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
08 Aug 23
Neuralink is engaged in the development of implantable brain-computer interfaces, which are designed to enable direct communication between…
31 Jul 23
Primary endpoints across three studies underscore the importance of accuracy, utility, and efficiency in coronary artery disease diagnostics…
24 Jul 23
The investment comes on the heels of the company's recent FDA Clearance for the Hubly Drill, a groundbreaking…
21 Jul 23
The OLO study is designed to evaluate the effectiveness of the Magnus neuromodulation system with SAINT technology for…
21 Jul 23
Rapid Medical pioneers advanced interventional devices to treat neurovascular diseases such as ischemic and hemorrhagic stroke.
19 Jul 23
The study’s data monitoring committee recommended that patient enrolment be continued up to the final planned sample size…
19 Jul 23
PTAB using the DETOUR System was first performed at Cleveland Clinic’s Sydell and Arnold Miller Family Heart, Vascular…
18 Jul 23
The MRI data from the Phase 2 study revealed that the proprietary gamma sensory stimulation therapy minimised the…
17 Jul 23
The new instruments are designed to assist the Intracept procedure, a same-day outpatient procedure that leverages targeted radiofrequency…
14 Jul 23
Evren is an innovator in the field of medical neuromodulation devices and is transforming the treatment of PTSD,…